Page 2 - Antoine Yver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5 00 at The Goldman Sachs Group

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5 00 at The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Antoine yverTial bushCentessa pharmaceuticals price performanceInstitutional trading of centessa pharmaceuticalsCentessa pharmaceuticalsSecurities exchange commissionAnalyst recommendations for centessa pharmaceuticalsCentessa pharmaceuticals company profileGoldman sachs groupJpmorgan chase coBlackrock incBarclays plcNews ratings for centessa pharmaceuticals dailyGeode capital managementGet free reportExchange commission

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8 4%

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8 4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverJpmorgan chase coInstitutional investors weigh in on centessa pharmaceuticalsNews ratings for centessa pharmaceuticals dailySecurities exchange commissionPrelude capital managementBarclays plcCentessa pharmaceuticalsSusquehanna international groupRenaissance technologiesCentessa pharmaceuticals stockGet free reportExchange commissionCapital managementInternational group

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase

Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increase
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverTanager wealth managementMorgan stanleyCentessa pharmaceuticalsCentessa pharmaceuticals trading downSio capital managementHedge funds weigh in on centessa pharmaceuticalsNews ratings for centessa pharmaceuticals dailySecurities exchange commissionGet free reportPharmaceuticals trading downExchange commissionWealth managementCapital managementCentessa pharmaceuticals daily

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11 7% Higher

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading 11 7% Higher
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Antoine yverTial bushCentessa pharmaceuticals company profileInstitutional trading of centessa pharmaceuticalsGeode capital managementGoldman sachs group incTanager wealth managementSecurities exchange commissionNews ratings for centessa pharmaceuticals dailyPrelude capital managementCentessa pharmaceuticalsCentessa pharmaceuticals stockGet free reportExchange commissionWealth managementCapital management

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15 00 by Analysts at BMO Capital Markets

Centessa Pharmaceuticals (NASDAQ:CNTA) Price Target Increased to $15 00 by Analysts at BMO Capital Markets
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverCentessa pharmaceuticals stock performanceCentessa pharmaceuticalsGeode capital managementPrelude capital managementInsider activity at centessa pharmaceuticalsAnalyst recommendations for centessa pharmaceuticalsJpmorgan chase coCentessa pharmaceuticals company profileBarclays plcNews ratings for centessa pharmaceuticals dailyFree reportModerate buyGet free reportState equity partners